MARKETSOcular therapeutix (ocul) stock soars on regeneron dealBy Annie PalmerOct 13, 2016 12:05 PM EDT
MARKETSToday's Weak On High Volume Stock: Ocular Therapeutix (OCUL)By TheStreet WireAug 9, 2016 10:00 AM EDT
MARKETSOcular therapeutix (ocl) stock soars, fda: corrective actions address concernsBy Rachel AldrichAug 4, 2016 12:38 PM EDT
MARKETSOcular Therapeutix (OCUL) Stock: Weak On High Volume TodayBy TheStreet WireJul 12, 2016 10:00 AM EDT
MARKETSStocks hover near session highs ahead of Yellen speechBy Keris Alison LahiffJun 6, 2016 11:22 AM EDT
MARKETSStock futures inch higher as Wall Street awaits YellenBy Keris Alison LahiffJun 6, 2016 7:44 AM EDT
OPINION3 biotech stocks with charts to watch -- and one bonus stock!By Harry BoxerApr 16, 2016 11:00 AM EDT
OPINIONThese 7 stocks under $10 are set to soar higher. Here's how to trade them.By Roberto PedoneMar 18, 2016 8:57 AM EDT
MARKETSTrade-Ideas: Ocular Therapeutix (OCUL) Is Today's Weak On High Relative Volume StockBy TheStreet WireFeb 18, 2016 10:03 AM EST
MARKETSOne Reason Why Ocular (OCUL) Stock is Advancing TodayBy Amanda AlbrightFeb 17, 2016 12:15 PM EST
OPINION5 Biotech Stocks Under $10 Triggering Breakout TradesBy Roberto PedoneOct 28, 2015 7:03 AM EDT
STOCKSOcular Therapeutix Eye-Pain Plug Flops Confirmatory Pivotal TrialBy Adam FeuersteinApr 6, 2015 5:22 PM EDT
INVESTINGOcular Therapeutix Eye-Pain Plug Benefits Still UnclearBy Adam FeuersteinMar 10, 2015 10:17 AM EDT
INVESTING14 IPOs You Wish You Bought in 2014 (and Made a Killing On)By Laurie KulikowskiFeb 5, 2015 8:36 AM EST
